iBoxit, a company based at Norwich Research Park, has been named as the winner of the Business Innovation Award at the Broadland and South Norfolk Business Awards 2025. iBoxit is a collaboration between entrepreneur John Farley and the University of East Anglia (UEA) under the tutelage of Prof Sheng Qi.
o2h discovery is excited to announce Ubiquigent as a winner of the o2h Kickstarter Competition. Ubiquigent Limited (Ubiquigent), a revenue- and IP-generating drug discovery company dedicated to enabling deubiquitinase (DUB)-focused drug discovery.
As part of the program, o2h discovery will provide Ubiquigent with access to chemists and associated end-to-end expertise to support its development of a novel portfolio of DUB-targeting compounds to enable the development of DUB-based therapeutics in partnership with its pharma and biotech partners.
• The top 20 global pharma companies, as a cohort, saw their combined R&D returns rise to 5.9% in 2024, up from 4.3% in 2023;
• GLP-1 drugs - which treat obesity and diabetes – are fuelling the surge, accounting for 2% of pharma’s forecast returns;
• Average cost to develop a drug has risen to $2.2 billion in 2024, up from $2.1 billion in 2023;
• 29 new ‘blockbuster assets’ (drugs with annual sales of at least $1 billion) have entered the drug development pipeline in 2024, up from 19 in 2023.
The LSX World Congress USA gathers leaders from the US biotech, medtech, and healthtech sectors to network, showcase innovations, and explore partnership opportunities. It offers a unique platform for CEOs, investors, and pharma executives to engage in meaningful discussions and collaborative sessions, shaping the future of healthcare technology.
*One Nucleus members receive 15% off registration. Please contact info@onenucleus.com for the discount code.
21 March 2025
Ahead of the long-awaited Industrial Strategy for life sciences, RSM UK calls on the government to address challenges around capital, talent and access to markets if the UK’s life sciences sector is to become an industry leader on the global stage.
The LSX World Congress gathers the founders and CEOs of innovative biotech, medtech and healthtech start-ups through to healthcare giants, and everyone in between.
They attend alongside the sector’s most active investors, pharma, medtech and healthtech BD&L teams and R&D leaders.
Key Responsibilities:
Assist with facilities management, including cleaning contract, security, waste, and maintenance.
Ensure health and safety compliance through inspections and risk assessments.
Act as a point of contact for Occupiers’ facilities-related queries.
Support campus events, logistics, and sustainability initiatives.
About You:
Experience in facilities or operational support.
Basic knowledge of health and safety (IOSH/NEBOSH desirable).
Strong organisational and communication skills.
Cancer Research Horizons, the innovation arm of Cancer Research UK, launches the Cancer Impact Club, a community of business builders whose philanthropy, expertise and networks will help shape the future of cancer treatment. The club has recruited 13 members already, raising £1.3m of its £5m target.
Summary of role:
Here at Domainex, with our two sites – one based on the Chesterford Research Park on the outskirts of Saffron Walden and one at the Unity Campus, just outside Sawston, on the outskirts of Cambridge - we are looking to expand our team with the addition of an Apprentice Associate Scientist focussing on a role based on the Unity Campus in our Biology Centre of Excellence.
Description of apprentice’s role and duties please specify particular tasks the apprentice will be expected to undertake as part of their role:
Guest blog by Romy Frow, Travel Counsellors
